PIM kinases regulate early human Th17 cell differentiation
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Tanja Buchacher und 13 weiteren Autor:innen. Beteiligte Einrichtung: Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Proto-Oncogene Proteins c-pim-1. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions, Juvenile Diabetes Research Foundation, European Union.
Abstract (Originalsprache)
The serine/threonine-specific Moloney murine leukemia virus (PIM) kinase family (i.e., PIM1, PIM2, and PIM3) has been extensively studied in tumorigenesis. PIM kinases are downstream of several cytokine signaling pathways that drive immune-mediated diseases. Uncontrolled T helper 17 (Th17) cell activation has been associated with the pathogenesis of autoimmunity. However, the detailed molecular function of PIMs in human Th17 cell regulation has yet to be studied. In the present study, we comprehensively investigated how the three PIMs simultaneously alter transcriptional gene regulation during early human Th17 cell differentiation. By combining PIM triple knockdown with bulk and scRNA-seq approaches, we found that PIM deficiency promotes the early expression of key Th17-related genes while suppressing Th1-lineage genes. Further, PIMs modulate Th cell signaling, potentially via STAT1 and STAT3. Overall, our study highlights the inhibitory role of PIMs in human Th17 cell differentiation, thereby suggesting their association with autoimmune phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland. Electronic address: tanja.buchacher@utu.fi.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland; Department of Microbiology and Immunology, Uni…
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland; Institute of Biomedicine, University of Turku,…
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland.
- Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Förderung
- H2020 Marie Skłodowska-Curie Actions
- Juvenile Diabetes Research Foundation
- European Union
- European Research Council
- Academy of Finland
- Cancer Foundation Finland
- Horizon 2020 Framework Programme
- Biocenter Finland
Zitieren
APA
Buchacher, T., Shetty, A., Koskela, S. A., Smolander, J., Kaukonen, R., Sousa, A. G. G., Junttila, S., Laiho, A., Rundquist, O., Lönnberg, T., Marson, A., Rasool, O., Elo, L. L., & Lahesmaa, R. (2023). PIM kinases regulate early human Th17 cell differentiation. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113469
Vancouver
Buchacher T, Shetty A, Koskela SA, Smolander J, Kaukonen R, Sousa AGG, et al. PIM kinases regulate early human Th17 cell differentiation. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113469
BibTeX
@article{Buchacher2023,
author = {Buchacher, Tanja and Shetty, Ankitha and Koskela, Saara A and Smolander, Johannes and Kaukonen, Riina and Sousa, António G G and Junttila, Sini and Laiho, Asta and Rundquist, Olof and Lönnberg, Tapio and Marson, Alexander and Rasool, Omid and Elo, Laura L and Lahesmaa, Riitta},
title = {PIM kinases regulate early human Th17 cell differentiation},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113469}
}
EUVIMED